Common Stock, Shares, Outstanding of Verrica Pharmaceuticals Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Verrica Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Verrica Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 17,178,786, a 87% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Verrica Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 17,178,786 +8,000,787 +87% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q3 2025 9,490,035 -36,110,760 -79% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 9,254,520 -33,201,533 -78% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 91,789,993 +49,369,940 +116% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 9,177,999 -33,235,554 -78% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q3 2024 45,600,795 +3,536,242 +8.4% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 42,456,053 +604,000 +1.4% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 42,420,053 +568,000 +1.4% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 42,413,553 +1,319,500 +3.2% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 42,064,553 +970,500 +2.4% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 41,852,053 +14,227,856 +52% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 41,852,053 +14,227,856 +52% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 41,094,053 +13,575,000 +49% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 41,094,053 +13,575,000 +49% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 27,624,197 +109,477 +0.4% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 27,624,197 +133,477 +0.49% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 27,519,053 +2,077,940 +8.2% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 27,519,053 +1,653,511 +6.4% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 27,514,720 +1,700,227 +6.6% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 27,490,720 +1,676,227 +6.5% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 25,441,113 -345,217 -1.3% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q3 2020 25,865,542 +120,745 +0.47% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 25,814,493 +74,196 +0.29% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 25,814,493 +106,008 +0.41% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 25,786,330 +81,574 +0.32% 31 Dec 2019 10-K 17 Mar 2021 2020 FY
Q3 2019 25,744,797 +48,426 +0.19% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 25,740,297 +43,926 +0.17% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 25,708,485 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 25,704,756 +22,005,257 +595% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 25,696,371 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 25,696,371 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q4 2017 3,699,499 31 Dec 2017 10-K 07 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.